Dependence Stage and Pharmacoeconomic Outcomes in Patients With Alzheimer Disease

Tzeyu L. Michaud, Robin High, Mary E. Charlton, Daniel L Murman

Research output: Contribution to journalArticle

Abstract

The level of assistance patients with Alzheimer disease (AD) require in their care may be an important predictor of resource use, costs of care, and quality of life. The Dependence Scale (DS), a measure of care-assistance required, was used to estimate costs of care and quality of life of patients with AD categorized into 6 dependence stages based upon the summated item scores of the DS. Data were derived from a 3-year, noninterventional study of 132 patients with probable AD (ages, 50 to 85 y) and caregiver dyads. We investigated the association between DS scores and health care costs, health-related quality of life (HRQoL), caregiver burden and estimated annual costs and HRQoL for 6 dependence stages in adjusted models. DS scores were significant predictors of health care costs, HRQoL, and caregiver burden. The estimated annual health care costs and a measure of HRQoL (EuroQoL-5D) ranged from $11,418 and 1.00 for those at very mild dependence stage to $101,715 and 0.26 for those at very severe dependence stage. DS scores classified into 6 dependence stages provides a useful method to estimate unique levels of care-associated costs and health utilities for pharmacoeconomic evaluations of new treatments for AD.

Original languageEnglish (US)
Pages (from-to)209-217
Number of pages9
JournalAlzheimer Disease and Associated Disorders
Volume31
Issue number3
DOIs
StatePublished - Jan 1 2017

Fingerprint

Pharmaceutical Economics
Alzheimer Disease
Quality of Life
Health Care Costs
Caregivers
Costs and Cost Analysis

Keywords

  • Alzheimer disease
  • costs of care
  • dependence scale
  • disease stage
  • pharmacoeconomic evaluation
  • quality of life

ASJC Scopus subject areas

  • Clinical Psychology
  • Gerontology
  • Geriatrics and Gerontology
  • Psychiatry and Mental health

Cite this

Dependence Stage and Pharmacoeconomic Outcomes in Patients With Alzheimer Disease. / Michaud, Tzeyu L.; High, Robin; Charlton, Mary E.; Murman, Daniel L.

In: Alzheimer Disease and Associated Disorders, Vol. 31, No. 3, 01.01.2017, p. 209-217.

Research output: Contribution to journalArticle

Michaud, Tzeyu L. ; High, Robin ; Charlton, Mary E. ; Murman, Daniel L. / Dependence Stage and Pharmacoeconomic Outcomes in Patients With Alzheimer Disease. In: Alzheimer Disease and Associated Disorders. 2017 ; Vol. 31, No. 3. pp. 209-217.
@article{58ce4b332c8b4507bdb0cfd09964f678,
title = "Dependence Stage and Pharmacoeconomic Outcomes in Patients With Alzheimer Disease",
abstract = "The level of assistance patients with Alzheimer disease (AD) require in their care may be an important predictor of resource use, costs of care, and quality of life. The Dependence Scale (DS), a measure of care-assistance required, was used to estimate costs of care and quality of life of patients with AD categorized into 6 dependence stages based upon the summated item scores of the DS. Data were derived from a 3-year, noninterventional study of 132 patients with probable AD (ages, 50 to 85 y) and caregiver dyads. We investigated the association between DS scores and health care costs, health-related quality of life (HRQoL), caregiver burden and estimated annual costs and HRQoL for 6 dependence stages in adjusted models. DS scores were significant predictors of health care costs, HRQoL, and caregiver burden. The estimated annual health care costs and a measure of HRQoL (EuroQoL-5D) ranged from $11,418 and 1.00 for those at very mild dependence stage to $101,715 and 0.26 for those at very severe dependence stage. DS scores classified into 6 dependence stages provides a useful method to estimate unique levels of care-associated costs and health utilities for pharmacoeconomic evaluations of new treatments for AD.",
keywords = "Alzheimer disease, costs of care, dependence scale, disease stage, pharmacoeconomic evaluation, quality of life",
author = "Michaud, {Tzeyu L.} and Robin High and Charlton, {Mary E.} and Murman, {Daniel L}",
year = "2017",
month = "1",
day = "1",
doi = "10.1097/WAD.0000000000000198",
language = "English (US)",
volume = "31",
pages = "209--217",
journal = "Alzheimer Disease and Associated Disorders",
issn = "0893-0341",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Dependence Stage and Pharmacoeconomic Outcomes in Patients With Alzheimer Disease

AU - Michaud, Tzeyu L.

AU - High, Robin

AU - Charlton, Mary E.

AU - Murman, Daniel L

PY - 2017/1/1

Y1 - 2017/1/1

N2 - The level of assistance patients with Alzheimer disease (AD) require in their care may be an important predictor of resource use, costs of care, and quality of life. The Dependence Scale (DS), a measure of care-assistance required, was used to estimate costs of care and quality of life of patients with AD categorized into 6 dependence stages based upon the summated item scores of the DS. Data were derived from a 3-year, noninterventional study of 132 patients with probable AD (ages, 50 to 85 y) and caregiver dyads. We investigated the association between DS scores and health care costs, health-related quality of life (HRQoL), caregiver burden and estimated annual costs and HRQoL for 6 dependence stages in adjusted models. DS scores were significant predictors of health care costs, HRQoL, and caregiver burden. The estimated annual health care costs and a measure of HRQoL (EuroQoL-5D) ranged from $11,418 and 1.00 for those at very mild dependence stage to $101,715 and 0.26 for those at very severe dependence stage. DS scores classified into 6 dependence stages provides a useful method to estimate unique levels of care-associated costs and health utilities for pharmacoeconomic evaluations of new treatments for AD.

AB - The level of assistance patients with Alzheimer disease (AD) require in their care may be an important predictor of resource use, costs of care, and quality of life. The Dependence Scale (DS), a measure of care-assistance required, was used to estimate costs of care and quality of life of patients with AD categorized into 6 dependence stages based upon the summated item scores of the DS. Data were derived from a 3-year, noninterventional study of 132 patients with probable AD (ages, 50 to 85 y) and caregiver dyads. We investigated the association between DS scores and health care costs, health-related quality of life (HRQoL), caregiver burden and estimated annual costs and HRQoL for 6 dependence stages in adjusted models. DS scores were significant predictors of health care costs, HRQoL, and caregiver burden. The estimated annual health care costs and a measure of HRQoL (EuroQoL-5D) ranged from $11,418 and 1.00 for those at very mild dependence stage to $101,715 and 0.26 for those at very severe dependence stage. DS scores classified into 6 dependence stages provides a useful method to estimate unique levels of care-associated costs and health utilities for pharmacoeconomic evaluations of new treatments for AD.

KW - Alzheimer disease

KW - costs of care

KW - dependence scale

KW - disease stage

KW - pharmacoeconomic evaluation

KW - quality of life

UR - http://www.scopus.com/inward/record.url?scp=85030831448&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85030831448&partnerID=8YFLogxK

U2 - 10.1097/WAD.0000000000000198

DO - 10.1097/WAD.0000000000000198

M3 - Article

C2 - 28486240

AN - SCOPUS:85030831448

VL - 31

SP - 209

EP - 217

JO - Alzheimer Disease and Associated Disorders

JF - Alzheimer Disease and Associated Disorders

SN - 0893-0341

IS - 3

ER -